Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development.